New Safety Device Designed to Support the Needs of Biologics FRANKLIN LAKES, N.J., April 11, 2013 -- (Healthcare Sales & Marketing Network) -- BD Medical, a segment of BD (Becton, Dickinson and Company) (BDX), a leading global medical technology compan...
Devices, FDA, Product Launch
BD , BD UltraSafe PLUS, Needle Guard

STOCKHOLM--(Healthcare Sales & Marketing Network)--Groundbreaking linear accelerator provides single system versatility to deliver sophisticated treatments for more patients and cancer types. Elekta (EKTAB.ST) recently received 510(k) clearance from the...
Devices, Oncology, FDA, Product Launch
Elekta, Versa HD, linear accelerator, radiotherapy

PARADISE VALLEY, AZ--(Healthcare Sales & Marketing Network) - Kaleidoscope Medical LLC, a medical device company developing innovative solutions for treating venous thromboembolic disease (VTE), announced today that it has closed its Series A financing. Pr...
Devices, Venture Capital
Kaleidoscope Medical, Venous Thromboembolism

NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by...
Biopharmaceuticals, Oncology, FDA
Pfizer, palbociclib, PD-0332991, breast cancer, Breakthrough Therapy designation

ROCKVILLE, Md., April 10, 2013 -- (Healthcare Sales & Marketing Network) -- Novavax, Inc. (NVAX) today announced the appointment of Amy B. Fix to the position of Vice President of Regulatory Affairs. She is responsible for directing regulatory strategy and...
Biopharmaceuticals, Personnel
Novavax, vaccine

Diverse pipeline reflected in four molecules targeting key cancer pathways WASHINGTON, April 10, 2013 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) unveiled data from four key molecules that represent the next generation of i...
Biopharmaceuticals, Oncology
Eli Lilly, LY2835219, LY2875358, LY2801653, LY2157299

Innovative Addition to our Galt Guidewire Products BUFORD, Ga.--(Healthcare Sales & Marketing Network)--Theragenics Corporation® (TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced tha...
Devices, Interventional, Product Launch
Theragenics, Galt Medical, Torx guidewire, Nitinol, transitionless guidewire

Adoption of Zio Patch System Reaches New Milestone -- Greater Than 20 Million Patient Hours of Monitoring SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - iRhythm Technologies, Inc., a medical device, service and technology company that devel...
Devices, Monitoring, Cardiology, Venture Capital
iRhythm Technologies, Zio Patch

SAN DIEGO--(Healthcare Sales & Marketing Network)--SpectraScience, Inc. (SCIE), a San Diego-based medical device company and PENTAX Europe GmbH (PENTAX Medical herein after) jointly announce that they have agreed on expanded distribution of the WavSTAT4 Op...
Devices, Oncology, Distribution
PENTAX Medical, SpectraScience, WavSTAT4, Optical Biopsy

The Christie NHS Foundation Trust to harness new linear accelerator to improve therapy for patients with head-and-neck, lung and prostate cancers MANCHESTER, England--(Healthcare Sales & Marketing Network)--Featuring a revolutionary combination of speed...
Devices, Oncology
Elekta, Versa HD, radiotherapy, linear accelerator

System Available in Canada and United States MINNEAPOLIS, MINNESOTA and BRAMPTON, ONTARIO--(Healthcare Sales & Marketing Network) - Medtronic, Inc. (MDT) today announced market release of the CardioGuide™ Implant System, a novel real-time navigation sys...
Devices, Cardiology, Product Launch
Medtronic, CardioGuide, pacemaker, defibrillator

FITCHBURG, MA--(Healthcare Sales & Marketing Network) - Arrhythmia Research Technology Inc. ("Company") (NYSE MKT: HRT) announces today that it has appointed Salvatore Emma, Jr. to serve as its President and Chief Executive Officer. Mr. Emma was ...
Devices, Cardiology, Personnel
Arrhythmia Research Technology

Seasoned Business Development Executive Chris Krueger Joins as Chief Business Officer FREMONT, Calif., April 9, 2013 -- (Healthcare Sales & Marketing Network) -- Zosano Pharma, Inc., a privately held pharmaceutical company developing products based on i...
Biopharmaceuticals, Drug Delivery, Personnel
Zosano Pharma, transdermal

SAN ANTONIO--(Healthcare Sales & Marketing Network)--Kinetic Concepts, Inc. today announced that Robert Hureau has been appointed Executive Vice President, Chief Financial Officer. As Executive Vice President, CFO, Hureau will be responsible for interna...
Devices, Wound Care, Personnel
Kinetic Concepts, V.A.C. Therapy

SAN FRANCISCO, April 9, 2013 -- (Healthcare Sales & Marketing Network) -- Cleave Biosciences announced today it has raised $10 million in an extension of its Series A financing from new investor New Enterprise Associates (NEA), bringing its Series A total...
Biopharmaceuticals, Oncology, Venture Capital, Personnel
Cleave Biosciences, ubiquitin, autophagy

BRIDGEWATER, N.J.--(Healthcare Sales & Marketing Network)--NovaDel Pharma Inc. (NVDL.PK) has signed a definitive agreement to sell its NovaMist™ technology and certain other assets to SUDA LTD, an Australian publicly held pharmaceutical company. The tra...
Biopharmaceuticals, Drug Delivery, Acquisitions
NovaDel Pharma, NovaMist, SUDA LTD

DUNDEE, Scotland, April 8, 2013 -- (Healthcare Sales & Marketing Network) --Professor Jonathan M Sackier has joined Vascular Flow Technologies, a global medical device company based in Dundee, Scotland as a Non-Executive Board Member. Professor Sackier is...
Devices, Personnel
Vascular Flow Technologies, Spiral Laminar Flow, SLF AV graft, LF PV graft

MONMOUTH JUNCTION, N.J., April 8, 2013 -- (Healthcare Sales & Marketing Network) -- CytoSorbents Corporation (CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, today announced the establishment of its Trau...
Devices, Personnel
CytoSorbents, CytoSorb

Terumo Europe NV is a wholly owned subsidiary of global medical device leader Terumo Corporation, which has nearly $5 billion in annual sales and operations in over 160 countries Exclusive agreement for distribution in 100 countries; potential market si...
Devices, Oncology, Distribution
BSD Medical, Terumo Europe, Terumo, MicroThermX, Microwave Ablation

MINNEAPOLIS--(Healthcare Sales & Marketing Network)--Monteris® Medical announced today that the U.S. FDA has issued a second 510(k) clearance for their MRI-guided ablation device for brain tumors and other lesions. The NeuroBlate® System is a secon...
Devices, Neurosurgery, FDA
Monteris Medical, NeuroBlate, MRI-guided ablation